Willis Simon N, Chen Lin, Dewson Grant, Wei Andrew, Naik Edwina, Fletcher Jamie I, Adams Jerry M, Huang David C S
The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Genes Dev. 2005 Jun 1;19(11):1294-305. doi: 10.1101/gad.1304105. Epub 2005 May 18.
Commitment of cells to apoptosis is governed largely by the interaction between members of the Bcl-2 protein family. Its three subfamilies have distinct roles: The BH3-only proteins trigger apoptosis by binding via their BH3 domain to prosurvival relatives, while the proapoptotic Bax and Bak have an essential downstream role involving permeabilization of organellar membranes and induction of caspase activation. We have investigated the regulation of Bak and find that, in healthy cells, Bak associates with Mcl-1 and Bcl-x(L) but surprisingly not Bcl-2, Bcl-w, or A1. These interactions require the Bak BH3 domain, which is also necessary for Bak dimerization and killing activity. When cytotoxic signals activate BH3-only proteins that can engage both Mcl-1 and Bcl-x(L) (such as Noxa plus Bad), Bak is displaced and induces cell death. Accordingly, the BH3-only protein Noxa could bind to Mcl-1, displace Bak, and promote Mcl-1 degradation, but Bak-mediated cell death also required neutralization of Bcl-x(L) by other BH3-only proteins. The results indicate that Bak is held in check solely by Mcl-1 and Bcl-x(L) and induces apoptosis only if freed from both. The finding that different prosurvival proteins have selective roles has notable implications for the design of anti-cancer drugs that target the Bcl-2 family.
细胞对凋亡的倾向很大程度上由Bcl-2蛋白家族成员之间的相互作用所调控。该家族的三个亚家族具有不同的作用:仅含BH3结构域的蛋白通过其BH3结构域与促生存相关蛋白结合来触发凋亡,而促凋亡蛋白Bax和Bak在下游具有关键作用,涉及细胞器膜的通透化和半胱天冬酶激活的诱导。我们研究了Bak的调控机制,发现健康细胞中,Bak与Mcl-1和Bcl-x(L)结合,但令人惊讶的是不与Bcl-2、Bcl-w或A1结合。这些相互作用需要Bak的BH3结构域,该结构域对Bak二聚化和杀伤活性也很必要。当细胞毒性信号激活能同时作用于Mcl-1和Bcl-x(L)的仅含BH3结构域的蛋白(如Noxa加Bad)时,Bak被置换并诱导细胞死亡。因此,仅含BH3结构域的蛋白Noxa可与Mcl-1结合,置换Bak并促进Mcl-1降解,但Bak介导的细胞死亡还需要其他仅含BH3结构域的蛋白中和Bcl-x(L)。结果表明,Bak仅受Mcl-1和Bcl-x(L)的抑制,只有当两者都被释放时才诱导凋亡。不同促生存蛋白具有选择性作用这一发现,对靶向Bcl-2家族的抗癌药物设计具有显著意义。